Purchase of own shares LONDON, UK / ACCESSWIRE / October 18, 2024 / The Company announces that on 17 October 2024 it purchased the following number of its ordinary shares of 20340/399pence each through Goldman Sachs International ("GSI") on the London Stock Exchange in accordance with the authority granted by shareholders at the Company's Annual General Meeting on 3 May 2024 (the "Purchase"). The Purchase was effected pursuant to instructions issued by the Company on 20 February 2024, as announced on 20 February 2024.
LONDON, UK / ACCESSWIRE / October 17, 2024 / The Company announces that on 16 October 2024 it purchased the following number of its ordinary shares of 20340/399pence each through Goldman Sachs International ("GSI") on the London Stock Exchange in accordance with the authority granted by shareholders at the Company's Annual General Meeting on 3 May 2024 (the "Purchase"). The Purchase was effected pursuant to instructions issued by the Company on 20 February 2024, as announced on 20 February 2024.
PUBLICATION DEMONSTRATES POTENTIAL FOR multi-marker CTC profiling IN EARLY PROSTATE CANCER Parsortix enriched CTCs detected at high rates in localised disease Multi-marker profiling of CTCs could support development of targeted therapies and help stratify patients in clinical trials GUILDFORD, SURREY / ACCESSWIRE / October 17, 2024 / ANGLE plc (AIM:AGL)(OTCQX:ANPCY), a world-leading liquid biopsy company with innovative circulating tumour cell (CTC) solutions for use in research, drug development and clinical oncology, is pleased to announce the publication of research investigating a panel of known prostate cancer gene transcripts in CTCs, undertaken by the Comprehensive Cancer Center at the Medical University of Vienna. Researchers used the Parsortix® system to isolate and harvest CTCs from 38 localised and metastatic prostate cancer patients.
LONDON, UNITED KINGDOM / ACCESSWIRE / October 16, 2024 / The Company announces that on 15 October 2024 it purchased the following number of its ordinary shares of 20340/399pence each through Goldman Sachs International ("GSI") on the London Stock Exchange in accordance with the authority granted by shareholders at the Company's Annual General Meeting on 3 May 2024 (the "Purchase"). The Purchase was effected pursuant to instructions issued by the Company on 20 February 2024, as announced on 20 February 2024.
Purchase of own shares LONDON, UK / ACCESSWIRE / October 15, 2024 / The Company announces that on 14 October 2024 it purchased the following number of its ordinary shares of 20340/399pence each through Goldman Sachs International ("GSI") on the London Stock Exchange in accordance with the authority granted by shareholders at the Company's Annual General Meeting on 3 May 2024 (the "Purchase"). The Purchase was effected pursuant to instructions issued by the Company on 20 February 2024, as announced on 20 February 2024.
Purchase of own shares LONDON, UNITED KINGDOM / ACCESSWIRE / October 14, 2024 / InterContinental Hotels Group PLC (the Company)(NYSE:IHG)(LSE:IHG)(OTC PINK:ICHGF) The Company announces that on 11 October 2024 it purchased the following number of its ordinary shares of 20340/399pence each through Goldman Sachs International ("GSI") on the London Stock Exchange in accordance with the authority granted by shareholders at the Company's Annual General Meeting on 3 May 2024 (the "Purchase"). The Purchase was effected pursuant to instructions issued by the Company on 20 February 2024, as announced on 20 February 2024.
Purchase of own shares LONDON, UNITED KINGDOM / ACCESSWIRE / October 11, 2024 / The Company announces that on 10 October 2024 it purchased the following number of its ordinary shares of 20340/399pence each through Goldman Sachs International ("GSI") on the London Stock Exchange in accordance with the authority granted by shareholders at the Company's Annual General Meeting on 3 May 2024 (the "Purchase"). The Purchase was effected pursuant to instructions issued by the Company on 20 February 2024, as announced on 20 February 2024.
Dismissal of Class Action Lawsuit (Murphy vs. Argo) LONDON, UK / ACCESSWIRE / October 11, 2024 / Argo is pleased to announce that the class action lawsuit, Murphy vs.
EASTLEIGH / ACCESSWIRE / October 10, 2024 / TR-1: Standard form for notification of major holdings 1. Issuer Details ISIN GB00BDHXPJ60 Issuer Name I3 ENERGY PLC UK or Non-UK Issuer UK 2.
LONDON, UNITED KINGDOM / ACCESSWIRE / October 10, 2024 / The Company announces that on 09 October 2024 it purchased the following number of its ordinary shares of 20340/399pence each through Goldman Sachs International ("GSI") on the London Stock Exchange in accordance with the authority granted by shareholders at the Company's Annual General Meeting on 3 May 2024 (the "Purchase"). The Purchase was effected pursuant to instructions issued by the Company on 20 February 2024, as announced on 20 February 2024.
LONDON, UK / ACCESSWIRE / October 9, 2024 / The Company announces that on 08 October 2024 it purchased the following number of its ordinary shares of 20340/399pence each through Goldman Sachs International ("GSI") on the London Stock Exchange in accordance with the authority granted by shareholders at the Company's Annual General Meeting on 3 May 2024 (the "Purchase"). The Purchase was effected pursuant to instructions issued by the Company on 20 February 2024, as announced on 20 February 2024.
Purchase of own shares LONDON, UK / ACCESSWIRE / October 8, 2024 / The Company announces that on 07 October 2024 it purchased the following number of its ordinary shares of 20340/399pence each through Goldman Sachs International ("GSI") on the London Stock Exchange in accordance with the authority granted by shareholders at the Company's Annual General Meeting on 3 May 2024 (the "Purchase"). The Purchase was effected pursuant to instructions issued by the Company on 20 February 2024, as announced on 20 February 2024.